169 related articles for article (PubMed ID: 34790823)
21. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
22. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract][Full Text] [Related]
23. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
[TBL] [Abstract][Full Text] [Related]
24. A risk signature of three autophagy-related genes for predicting lower grade glioma survival is associated with tumor immune microenvironment.
Lin JZ; Lin N
Genomics; 2021 Jan; 113(1 Pt 2):767-777. PubMed ID: 33069830
[TBL] [Abstract][Full Text] [Related]
25. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
26. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
[TBL] [Abstract][Full Text] [Related]
27. Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas.
Yang W; Yu H; Lei Q; Pu C; Guo Y; Lin L
Sci Rep; 2024 May; 14(1):11874. PubMed ID: 38789729
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma.
Chen X; Zhang W; Zhu H; Lin F
Med Sci Monit; 2021 Feb; 27():e928949. PubMed ID: 33577492
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract][Full Text] [Related]
30. Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients.
Liao S; He J; Liu C; Zhang Z; Liao H; Liao Z; Yu C; Guan J; Mo H; Yuan Z; Liang T; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2021 Jun; 100(22):e26219. PubMed ID: 34087900
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB
J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759
[TBL] [Abstract][Full Text] [Related]
32. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
33. A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma.
Lin T; Cheng H; Liu D; Wen L; Kang J; Xu L; Shan C; Chen Z; Li H; Lai M; Zhou Z; Hong W; Hu Q; Li S; Zhou C; Geng J; Jin X
Front Genet; 2021; 12():698284. PubMed ID: 34721517
[TBL] [Abstract][Full Text] [Related]
34. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
[TBL] [Abstract][Full Text] [Related]
35. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
36. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Hu D; Jiang L; Luo S; Zhao X; Hu H; Zhao G; Tang W
J Transl Med; 2020 Apr; 18(1):160. PubMed ID: 32264916
[TBL] [Abstract][Full Text] [Related]
37. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
Wei B; Wang L; Zhao J
Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
[TBL] [Abstract][Full Text] [Related]
39. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.
Zheng J; Wu Z; Qiu Y; Wang X; Jiang X
J Transl Med; 2022 Jan; 20(1):55. PubMed ID: 35093128
[TBL] [Abstract][Full Text] [Related]
40. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
Front Immunol; 2020; 11():606164. PubMed ID: 33408717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]